Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
0 Total Attendees
Total
Uniques
Total
Uniques
Total
Uniques
535 East 70th Street, New York, NY 10021
Scleroderma is a rare, complex autoimmune connective tissue disease characterized by fibrosis, vasculopathy, and immune dysregulation. Early recognition and therapy benefits patients, particularly related to internal organ involvement, such as pulmonary arterial hypertension and interstitial lung disease, and digital ischemia. Join us to learn about evidence-based approaches to systemic sclerosis (SSc), including novel, emerging treatments.
Highlights include:
Emerging therapies (cellular and non-cellular) for systemic sclerosis, including mechanisms, evidence from clinical trials, and patient selection criteria.
Current best practices in diagnosing and managing ILD, gastrointestinal involvement, Raynaud’s phenomenon, and pulmonary hypertension in SSc, incorporating advanced imaging and evolving treatment algorithms.
Differentiation of scleroderma skin disease from mimics and strategies for managing skin fibrosis and dermatologic complications.
Multidisciplinary management, including rheumatology, gastroenterology, pulmonology, cardiology, dermatology, orthopedics, and rehabilitation, to optimize outcomes for patients with systemic sclerosis.
535 East 70th Street, New York, NY 10021